Get the Stockscreener App
64.60
1.44%
0.92
Pre-market:
64.99
0.39
+0.60%
Caredx Inc stock is traded at $64.60, with a volume of 1.08M.
It is up +1.44% in the last 24 hours and up +29.74% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$63.68
Open:
$62.3
24h Volume:
1.08M
Relative Volume:
0.90
Market Cap:
$3.34B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-419.21
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
+18.90%
1M Performance:
+29.74%
6M Performance:
+284.98%
1Y Performance:
+332.69%
1-Day Range:
$62.30
$65.50
1-Week Range:
$53.78
$65.50
52-Week Range:
$13.95
$65.50
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
64.60 | 3.29B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
678.60 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
227.33 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
411.77 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.21 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.97 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx, Inc. (CDNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
CareDx Refocused On Transplant Testing, And Wall Street Noticed - Finimize
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Singapore
How (CDNA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade) - Seeking Alpha
Biotech Stocks At 52-Week HighsCDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY - RTTNews
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar? - Yahoo Finance
CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100 - GuruFocus
CareDx +14% on Fresh $74 Analyst Price Target - TIKR.com
BTIG raises CareDx stock price target to $74 on transplant outlook - Investing.com
CDNA Maintained by BTIG -- Price Target Raised to $74.00 - GuruFocus
BTIG raises CareDx stock price target to $74 on transplant outlook By Investing.com - Investing.com South Africa
CareDx Is Maintained at Buy by BTIG - Moomoo
CareDx, Inc (CDNA) stock price, news, quote and history - uk.finance.yahoo.com
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions - Yahoo Finance
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently - Benzinga
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.41 v - GuruFocus
Caredx Inc stock hits 52-week high at 55.21 USD - Investing.com
Caredx Inc stock hits 52-week high at 55.21 USD By Investing.com - Investing.com Nigeria
CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Behalf of CareDx, Inc. Limited Shareholders - TMX Newsfile
Naveris: 2025 revenue $34,337,000 (CareDx 8-K/A) - Dealroom.co
CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case - ChartMill
CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector - DirectorsTalk Interviews
CareDx (CDNA) CFO uses 8,220 shares to cover RSU taxes - Stock Titan
CareDx (NASDAQ: CDNA) CCO has 6,688 shares withheld for taxes - Stock Titan
Caredx Inc stock hits 52-week high at 53.71 USD By Investing.com - Investing.com Nigeria
Caredx Inc stock hits 52-week high at 53.71 USD - Investing.com
CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum - ChartMill
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks - TradingView
CareDx (CDNA) Q2 2026 Earnings: EPS of $0.37 Beats Estimates by 55.79%Earnings Call Q&A - careplusvn.com
Are Medical Stocks Lagging CareDx (CDNA) This Year? - Yahoo Finance
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup - ChartMill
CareDx (CDNA) Pulls Back to $48.92 as Transplant Diagnostics Stock Holds Range Between Support and ResistanceStop Loss Guidance - careplusvn.com
CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65 - GuruFocus
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings - GenomeWeb
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com South Africa
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target - marketscreener.com
Canaccord initiates CareDx stock coverage with buy rating on testing - Investing.com India
CareDx (CDNA) Holds Steady at $50.11; Resistance at $52.62 in FocusOutside Reversal - careplusvn.com
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Eastern Progress
Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 49.77 USD - Investing.com
Is CareDx’s AI and EHR Push Reshaping Its Role In Transplant Care Infrastructure (CDNA)? - Sahm
Zacks Industry Outlook CareDx, BrightSpring and PACS - Yahoo Finance
CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now? - Yahoo Finance
Is CareDx (CDNA) Fully Priced After Its Strong Three Year Run? - Yahoo Finance
Is CareDx Inc (CDNA) Overvalued After 3.5% Rally? GF Value Says - GuruFocus
CareDx Inc (1K9) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
CareDx Inc (1K9) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):